Cigna joins the VC fray with new $250 million venture fund
Cigna competitors who have launched their own venture arms include Humana, Kaiser Permanente and UnitedHealthGroup's Optum division.
Cigna competitors who have launched their own venture arms include Humana, Kaiser Permanente and UnitedHealthGroup's Optum division.
Prognos, a New York City-based artificial intelligence company, has wrapped up a $20.5 million Series C financing round from investors such as Cigna, Merck Global Health Innovation Fund, Hermed, Hikma Ventures, GIS Strategic Ventures, Maywic and Safeguard Scientifics.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
As part of the relaunch, New York-based Prognos is making an aggressive push into the payer market to augment its predictive analytics work with life sciences and diagnostics clients.